TCL Archive Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months September 26, 2014
TCL Archive Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34% June 28, 2013
TCL Archive In Brief: Friedman Named FDA Deputy Commissioner; Parkinson To Lead CTEP; Walsh Resigns September 22, 1995